PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
07-Sep-2020 AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Asklepios BioPharmaceutical, Inc.
07-Sep-2020 New 12-month analysis data from ETNA-AF non-interventional study show low bleeding and ICH rates in frail and ageing AF patients on LIXIANA®▼ (edoxaban) during routine clinical care Daiichi Sankyo Europe
07-Sep-2020 Hikma receives favourable court ruling for its generic Vascepa® Hikma Pharmaceuticals PLC
07-Sep-2020 Miele offers savings across lab washer range Miele
07-Sep-2020 SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS SPRAVATO®▼ (ESKETAMINE) NASAL SPRAY FOR USE IN TREATMENT OF ADULTS WITH TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER IN SCOTLAND Janssen
01-Sep-2020 Sanofi to commence tender offer for acquisition of Principia Biopharma Inc. Sanofi
01-Sep-2020 Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies The Institute of Cancer Research
01-Sep-2020 Empagliflozin (Jardiance®) meets primary endpoint in Phase III heart failure trial with and without diabetes Boehringer Ingelheim and Eli Lilly and Company (Lilly)
01-Sep-2020 SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics SOTIO
01-Sep-2020 Biocartis Expands Collaboration with LifeArc Biocartis Group NV
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV
01-Sep-2020 Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S. Sanofi
01-Sep-2020 Induction subsidiary Horizon achieves earn-out target ahead of schedule Induction Healthcare Group PLC
01-Sep-2020 Emergex Vaccines forms US subsidiary (Emergex USA) by acquisition of laboratories, technology and assets of US-based T cell specialist biotech ImmProNano Emergex Vaccines Holding Limited
01-Sep-2020 BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development BioVersys
01-Sep-2020 Chromologics Announces Seed Round Led by Novo Holdings and Supported by Vækstfonden and Nordic FoodTech VC Chromologics
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV
01-Sep-2020 CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management CluePoints S.A.
01-Sep-2020 NILEMDO®▼(bempedoic acid) delivers cholesterol lowering in addition to statin therapy which is maintained during 2.5 years of treatment Daiichi Sankyo Europe GmbH
01-Sep-2020 Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer AstraZeneca